Literature DB >> 22524806

Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women.

Suebwong Chuthapisith1, Watthanasak Permsapaya, Malee Warnnissorn, Charuwan Akewanlop, Vorapan Sirivatanauksorn, Poramaporn Prasarttong Osoth.   

Abstract

Expression of estrogen-receptor (ER), progesterone-receptor (PR) and HER-2 has recently been linked with various breast cancer subtypes identified by gene microarray. This study aimed to document breast cancer subtypes based on ER, PR and HER-2 status in Thai women, where expression of these subtypes may not be similar to those evident in Western women. During 2009 to 2010, histological findings from 324 invasive ductal carcinomas (IDC) at Siriraj Hospital were studied. Various subtypes of IDC were identified according to expression of ER, PR and HER-2: luminal-A (ER+;PR+/-;HER-2-), luminal-B (ER+;PR+/-;HER-2+), HER-2 (ER-;PR- ;HER-2+) and basal-like (ER-;PR-;HER-2-). As well, associations of tumor size, tumor grade, nodal status, angiolymphatic invasion (ALI), multicentricity and multifocality with different breast cancer subtypes were studied. Of 324 IDCs, 143 (44.1%), 147 (45.4%), 15 (4.6%) and 12 (3.7%) were T1, T2, T3 and T4, respectively. Most tumors were grade 2 (54.9%) and had no nodal involvement (53.4%). According to ER, PR and HER-2 status, 192 (59.3%), 40 (12.3%), 43 (13.3%) and 49 (15.1%) tumors were luminal-A, luminal-B, HER-2 and basal-like subtypes. HER-2 subtype presented with large tumor (p=0.04, ANOVA). Luminal-A IDC was associated with single foci (p<0.01, χ2). HER-2 and basal-like subtypes were likely to have high tumor grade (p<0.01, χ2). In addition, HER-2 subtype had higher number of nodal involvement (p=0.048, χ2). In conclusion, the luminal-A subtype accounted for the majority of IDCs in Thai women. Percentages of HER-2 and basal-like IDCs were high, compared with a recent study from the USA. The HER-2 subtype was related with high nodal invasion. The findings may highlight biological differences between IDCs occurring in Asian and Western women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524806     DOI: 10.7314/apjcp.2012.13.2.459

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Breast cancer molecular subtypes of Uygur and Han in Xinjiang of China.

Authors:  Cheng-Hui Wang; Jun-Zhi Li; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

Authors:  Ebru Esin Yoruker; Fatma Aydoğan; Uğur Gezer; Pinar Saip; Nejat Dalay
Journal:  Mol Clin Oncol       Date:  2015-05-13

3.  Identification of specific microRNA-messenger RNA regulation pairs in four subtypes of breast cancer.

Authors:  Ling Guo; Aihua Zhang; Jie Xiong
Journal:  IET Syst Biol       Date:  2020-06       Impact factor: 1.615

4.  Significance of ERβ expression in different molecular subtypes of breast cancer.

Authors:  Liying Guo; Jie Meng; Dilimina Yilamu; Adina Jakulin; Minggang Fu; Bowei Wang; Gulinaer Abulajiang
Journal:  Diagn Pathol       Date:  2014-01-23       Impact factor: 2.644

5.  Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes

Authors:  Irianiwati Widodo; Ery Kus Dwianingsih; Sumadi Lukman Anwar; Triningsih Fx Ediati; Totok Utoro; Teguh Aryandono
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

6.  Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand.

Authors:  Supinda Koonmee; Ongart Somintara; Piyapharom Intarawichian; Chaiwat Aphivatanasiri; Sakkarn Sangkhamanon; Suphawat Laohawiriyakamol; Rujira Panawattanakul; Phanchanut Mahantassanapong; Chayanoot Rattadilok; Piyarat Jeeravongpanich; Wilart Krongyute; Krisada Prachumrasee; Reza Alaghehbandan
Journal:  Cancer Manag Res       Date:  2021-11-23       Impact factor: 3.989

7.  Patients' preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments.

Authors:  Surachat Ngorsuraches; Klangjai Thongkeaw
Journal:  Springerplus       Date:  2015-11-05

8.  Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size

Authors:  Yeni Rahmawati; Yunita Setyawati; Irianiwati Widodo; Ahmad Ghozali; Dewajani Purnomosari
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

9.  Developing a risk prediction model for breast cancer: a Statistical Utility to Determine Affinity of Neoplasm (SUDAN-CA Breast).

Authors:  Alaaddin M Salih; Dafallah M Alam-Elhuda; Musab M Alfaki; Adil E Yousif; Momin M Nouradyem
Journal:  Eur J Med Res       Date:  2017-09-29       Impact factor: 2.175

10.  Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas

Authors:  Irianiwati Widodo; Ery Kus Dwianingsih; Totok Utoro; Sumadi Lukman Anwar; Teguh Aryandono; Soeripto Soeripto
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.